Morgan Stanley Cellebrite Di Ltd. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Cellebrite Di Ltd. stock. As of the latest transaction made, Morgan Stanley holds 5,375,390 shares of CLBT stock, worth $106 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,375,390

Previous 6,991,071 23.11%

Holding current value

$106 Million

Previous $83.5 Million 8.35%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$11.61 - $17.52 $18.8 Million - $28.3 Million	-1,615,681 Reduced 23.11%	5,375,390 $90.5 Million
Q2 2024 Oct 17, 2024	BUY	$10.38 - $12.5 $29.8 Million - $35.8 Million	2,866,806 Added 69.51%	6,991,071 $83.5 Million
Q2 2024 Aug 14, 2024	BUY	$10.38 - $12.5 $29.8 Million - $35.8 Million	2,866,806 Added 69.51%	6,991,071 $83.5 Million
Q1 2024 Oct 17, 2024	SELL	$8.04 - $12.29 $23 Million - $35.2 Million	-2,866,806 Reduced 41.01%	4,124,265 $45.7 Million
Q1 2024 Aug 16, 2024	BUY	$8.04 - $12.29 $4.12 Million - $6.3 Million	512,894 Added 14.2%	4,124,265 $45.7 Million
Q1 2024 May 15, 2024	BUY	$8.04 - $12.29 $4.12 Million - $6.3 Million	512,894 Added 14.2%	4,124,265 $45.7 Million
Q4 2023 Aug 16, 2024	SELL	$6.45 - $8.76 $21.8 Million - $29.6 Million	-3,379,700 Reduced 48.34%	3,611,371 $31.3 Million
Q4 2023 Feb 13, 2024	BUY	$6.45 - $8.76 $8.23 Million - $11.2 Million	1,276,478 Added 54.67%	3,611,371 $31.3 Million
Q3 2023 Nov 15, 2023	BUY	$6.86 - $8.18 $1.22 Million - $1.46 Million	178,058 Added 8.26%	2,334,893 $17.9 Million
Q2 2023 Aug 14, 2023	BUY	$5.3 - $7.2 $203,149 - $275,976	38,330 Added 1.81%	2,156,835 $15.5 Million
Q1 2023 May 15, 2023	SELL	$4.36 - $6.15 $115,012 - $162,230	-26,379 Reduced 1.23%	2,118,505 $12.9 Million
Q4 2022 Feb 14, 2023	BUY	$3.99 - $4.95 $8.54 Million - $10.6 Million	2,140,900 Added 53737.45%	2,144,884 $9.35 Million
Q3 2022 Nov 14, 2022	SELL	$0.75 - $5.95 $1,732 - $13,744	-2,310 Reduced 36.7%	3,984 $15,000
Q2 2022 Oct 27, 2022	BUY	$4.46 - $7.19 $307 - $496	69 Added 1.11%	6,294 $31,000
Q2 2022 Aug 15, 2022	BUY	$4.46 - $7.19 $307 - $496	69 Added 1.11%	6,294 $31,000
Q1 2022 Oct 27, 2022	SELL	$5.34 - $8.12 $368 - $560	-69 Reduced 1.1%	6,225 $40,000
Q1 2022 May 13, 2022	SELL	$5.34 - $8.12 $67,951 - $103,326	-12,725 Reduced 67.15%	6,225 $40,000
Q4 2021 Feb 14, 2022	BUY	$7.8 - $11.24 $98,412 - $141,815	12,617 Added 199.23%	18,950 $152,000
Q3 2021 Nov 15, 2021	BUY	$9.26 - $12.15 $58,643 - $76,945	6,333 New	6,333 $58,000

Others Institutions Holding CLBT

# of Institutions

175

Shares Held

108M

Call Options Held

741K

Put Options Held

205K

View Full List

About Cellebrite DI Ltd.

Ticker CLBT
Exchange NASDAQ
Sector Technology
Industry Software—Infrastructure
Shares Outstandng 189,648,992
Market Cap $3.74B
Description
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border c...

More about CLBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account